Both high level pressure support ventilation and controlled mechanical ventilation induce diaphragm dysfunction and atrophy
- 1 April 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 40 (4) , 1254-1260
- https://doi.org/10.1097/ccm.0b013e31823c8cc9
Abstract
Previous workers have demonstrated that controlled mechanical ventilation results in diaphragm inactivity and elicits a rapid development of diaphragm weakness as a result of both contractile dysfunction and fiber atrophy. Limited data exist regarding the impact of pressure support ventilation, a commonly used mode of mechanical ventilation—that permits partial mechanical activity of the diaphragm—on diaphragm structure and function. We carried out the present study to test the hypothesis that high-level pressure support ventilation decreases the diaphragm pathology associated with CMV. Sprague-Dawley rats were randomly assigned to one of the following five groups:1) control (no mechanical ventilation); 2) 12 hrs of controlled mechanical ventilation (12CMV); 3) 18 hrs of controlled mechanical ventilation (18CMV); 4) 12 hrs of pressure support ventilation (12PSV); or 5) 18 hrs of pressure support ventilation (18PSV). We carried out the following measurements on diaphragm specimens: 4-hydroxynonenal—a marker of oxidative stress, active caspase-3 (casp-3), active calpain-1 (calp-1), fiber type cross-sectional area, and specific force (sp F). Compared with the control, both 12PSV and 18PSV promoted a significant decrement in diaphragmatic specific force production, but to a lesser degree than 12CMV and 18CMV. Furthermore, 12CMV, 18PSV, and 18CMV resulted in significant atrophy in all diaphragm fiber types as well as significant increases in a biomarker of oxidative stress (4-hydroxynonenal) and increased proteolytic activity (20S proteasome, calpain-1, and caspase-3). Furthermore, although no inspiratory effort occurs during controlled mechanical ventilation, it was observed that pressure support ventilation resulted in large decrement, approximately 96%, in inspiratory effort compared with spontaneously breathing animals. High levels of prolonged pressure support ventilation promote diaphragmatic atrophy and contractile dysfunction. Furthermore, similar to controlled mechanical ventilation, pressure support ventilation-induced diaphragmatic atrophy and weakness are associated with both diaphragmatic oxidative stress and protease activation. (Crit Care Med 2012; 40:–1260)Keywords
This publication has 54 references indexed in Scilit:
- Oxidative stress is required for mechanical ventilation-induced protease activation in the diaphragmJournal of Applied Physiology, 2010
- Prolonged mechanical ventilation alters diaphragmatic structure and functionCritical Care Medicine, 2009
- Apocynin attenuates diaphragm oxidative stress and protease activation during prolonged mechanical ventilationCritical Care Medicine, 2009
- Pressure support ventilation attenuates ventilator-induced protein modifications in the diaphragmCritical Care, 2008
- Antioxidant administration attenuates mechanical ventilation‐induced rat diaphragm muscle atrophy independent of protein kinase B (PKB–Akt) signallingThe Journal of Physiology, 2007
- Caspase-3 Regulation of Diaphragm Myonuclear Domain during Mechanical Ventilation–induced AtrophyAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Mechanisms of skeletal muscle atrophyCurrent Opinion in Rheumatology, 2006
- Clinical review: Patient-ventilator interaction in chronic obstructive pulmonary diseaseCritical Care, 2006
- Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuseThe Journal of Physiology, 2002
- Kinetic Characterization of the Chymotryptic Activity of the 20S ProteasomeBiochemistry, 1996